Bladder Cancer Academy 2017

Bladder Cancer Academy

Why LUGPA Embraces Managing Advanced Genitourinary Cancers

Neal Shore, MD, FACS

Medical Director, Certified Physician Investigator
Carolina Urologic Research Center
Atlantic Urology Clinics

Bladder Cancer Biomarkers: New and Old

Michael Cookson, MD

Professor & Chairman, Department of Urology
The University of Oklahoma Health Sciences Center

AUA Guidelines: Non-muscle Invasive Bladder Cancer

Sam Chang, MD

Professor of Urologic Surgery and Oncology
Vanderbilt University Medical Center

Intravesical Therapy: When Bacillus Calmette-Guerin Fails

Noah Hahn, MD

Associate Professor of Oncology and Urology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Director, Bladder Cancer Medical Oncology Program

Bladder-sparing Strategies

Trinity Bivalacqua, MD, PhD

Director of Urology Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Johns Hopkins Medical Institutions

Immunotherapy for Advanced Bladder Cancer: The Next Frontier

Arjun Balar, MD

Assistant Professor, Department of Medicine
Director, Genitourinary Medical Oncology Program
NYU Langone Medical Center

Targeted Therapies for Renal Cell Carcinoma

Won Kim, MD

Assistant Professor of Medicine and Urology
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Immunotherapy of Renal Cell Carcinoma

Hans Hammers, MD, PhD

Associate Professor, Internal Medicine
Division of Hematology and Oncology
UT Southwestern – Kidney Cancer Program

Genitourinary Oncology: A Peek Over the Horizon

Dan Theodorescu, MD, PhD

Paul A. Bunn, Jr. Endowed Chair in Cancer Research
Professor of Surgery and Pharmacology
Director, University of Colorado Cancer Center